Firefly Neuroscience (AIFF) Competitors $2.71 +0.12 (+4.63%) Closing price 04:00 PM EasternExtended Trading$2.74 +0.02 (+0.92%) As of 05:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock AIFF vs. EXFY, SVCO, AEYE, ARBE, SKIL, ALAR, RMBL, CCLD, MYPS, and CSPIShould you be buying Firefly Neuroscience stock or one of its competitors? The main competitors of Firefly Neuroscience include Expensify (EXFY), Silvaco Group (SVCO), Audioeye (AEYE), Arbe Robotics (ARBE), Skillsoft (SKIL), Alarum Technologies (ALAR), RumbleON (RMBL), CareCloud (CCLD), PLAYSTUDIOS (MYPS), and CSP (CSPI). These companies are all part of the "computer software" industry. Firefly Neuroscience vs. Its Competitors Expensify Silvaco Group Audioeye Arbe Robotics Skillsoft Alarum Technologies RumbleON CareCloud PLAYSTUDIOS CSP Firefly Neuroscience (NASDAQ:AIFF) and Expensify (NASDAQ:EXFY) are both small-cap business services companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, risk, earnings, valuation, media sentiment and analyst recommendations. Do analysts recommend AIFF or EXFY? Expensify has a consensus price target of $4.00, suggesting a potential upside of 115.05%. Given Expensify's stronger consensus rating and higher probable upside, analysts plainly believe Expensify is more favorable than Firefly Neuroscience.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Firefly Neuroscience 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Expensify 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50 Does the media favor AIFF or EXFY? In the previous week, Expensify had 4 more articles in the media than Firefly Neuroscience. MarketBeat recorded 8 mentions for Expensify and 4 mentions for Firefly Neuroscience. Firefly Neuroscience's average media sentiment score of 0.00 beat Expensify's score of -0.41 indicating that Firefly Neuroscience is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Firefly Neuroscience 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Expensify 0 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do institutionals & insiders hold more shares of AIFF or EXFY? 5.0% of Firefly Neuroscience shares are held by institutional investors. Comparatively, 68.4% of Expensify shares are held by institutional investors. 8.4% of Firefly Neuroscience shares are held by insiders. Comparatively, 17.3% of Expensify shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Is AIFF or EXFY more profitable? Expensify has a net margin of -10.72% compared to Firefly Neuroscience's net margin of -5,335.75%. Expensify's return on equity of -12.02% beat Firefly Neuroscience's return on equity.Company Net Margins Return on Equity Return on Assets Firefly Neuroscience-5,335.75% -464.02% -245.47% Expensify -10.72%-12.02%-8.52% Which has higher earnings & valuation, AIFF or EXFY? Expensify has higher revenue and earnings than Firefly Neuroscience. Expensify is trading at a lower price-to-earnings ratio than Firefly Neuroscience, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFirefly Neuroscience$428K84.80-$10.46M-$2.50-1.08Expensify$139.24M1.08-$10.06M-$0.16-11.63 Which has more risk and volatility, AIFF or EXFY? Firefly Neuroscience has a beta of 3.2, indicating that its stock price is 220% more volatile than the S&P 500. Comparatively, Expensify has a beta of 1.72, indicating that its stock price is 72% more volatile than the S&P 500. SummaryExpensify beats Firefly Neuroscience on 12 of the 16 factors compared between the two stocks. Get Firefly Neuroscience News Delivered to You Automatically Sign up to receive the latest news and ratings for AIFF and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AIFF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AIFF vs. The Competition Export to ExcelMetricFirefly NeuroscienceTechnology Services IndustryBusiness SectorNASDAQ ExchangeMarket Cap$36.30M$2.68B$26.00B$9.77BDividend YieldN/A1.56%2.78%4.08%P/E Ratio-1.0823.5428.3326.04Price / Sales84.8048.90990.54104.72Price / CashN/A39.8225.5828.79Price / Book-54.206.936.776.08Net Income-$10.46M$34.86M$197.91M$265.64M7 Day Performance2.26%4.30%11.86%3.11%1 Month Performance-7.51%-3.45%4.19%0.39%1 Year Performance-46.23%54.18%44.71%18.52% Firefly Neuroscience Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AIFFFirefly NeuroscienceN/A$2.71+4.6%N/AN/A$36.30M$428K-1.08N/ANews CoverageGap UpHigh Trading VolumeEXFYExpensify2.9246 of 5 stars$1.75-3.3%$4.00+128.6%-24.7%$145.79M$139.24M-10.94140SVCOSilvaco Group2.7049 of 5 stars$4.53-3.8%$14.20+213.5%-72.2%$143.10M$59.68M-4.19N/AAEYEAudioeye3.6801 of 5 stars$11.30+0.5%$25.25+123.5%-48.9%$139.53M$38.24M-33.23110Positive NewsARBEArbe Robotics2.6556 of 5 stars$1.20-7.0%$2.25+87.5%-34.0%$135.81M$770K-2.14120SKILSkillsoftN/A$14.48-3.3%N/A+33.5%$128.34M$530.99M-0.902,261News CoverageALARAlarum Technologies2.0558 of 5 stars$16.40-3.6%$17.50+6.7%-22.5%$120.59M$31.82M24.4860News CoveragePositive NewsUpcoming EarningsAnalyst ForecastGap DownRMBLRumbleON1.4738 of 5 stars$3.18+58.8%$4.50+41.7%-33.1%$120.02M$1.11B-1.061,928Gap UpHigh Trading VolumeCCLDCareCloud1.9724 of 5 stars$2.72flat$2.50-8.1%+10.0%$115.12M$110.84M-68.003,650News CoverageGap UpMYPSPLAYSTUDIOS2.497 of 5 stars$0.96+4.3%$2.50+161.0%-35.8%$115.12M$289.43M-3.99510CSPICSP0.5176 of 5 stars$11.22-3.7%N/A-9.8%$114.88M$55.22M-66.00120 Related Companies and Tools Related Companies EXFY Competitors SVCO Competitors AEYE Competitors ARBE Competitors SKIL Competitors ALAR Competitors RMBL Competitors CCLD Competitors MYPS Competitors CSPI Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AIFF) was last updated on 8/26/2025 by MarketBeat.com Staff From Our PartnersThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 30th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Firefly Neuroscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Firefly Neuroscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access